- Kimberly-Clark to Buy Tylenol Maker Kenvue. Why KMB Stock Is Tanking. Barron’s
- Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal AP News
- With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm The New York Times
- Exclusive | Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day. The Wall Street Journal
- Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy Reuters
